Rare diseases
Investigational molecules
Locations
Back to Germany248 clinical trials in Giessen, Germany across 1 research site. Every trial is listed in the EU Clinical Trials Register and updated daily.
Our site in GermanyKlinischeStudien.de(opens in a new tab)GermanyStudy on Bulevirtide Treatment for Patients with Chronic Hepatitis D
GermanyStudy on the Safety and Effectiveness of MK-5475 for Adults with Pulmonary Hypertension and COPD
GermanyStudy on the Safety and Effectiveness of Stereotactic Body Radiotherapy with or without Pembrolizumab for Patients with Unresected Stage I or II Non-Small Cell Lung Cancer
GermanyStudy of Telisotuzumab Vedotin for Adults with Advanced Non-Squamous Non-Small Cell Lung Cancer
GermanyStudy on Physical Activity and Joint Health in Patients Aged 12 and Older with Severe Hemophilia A Treated with Efanesoctocog Alfa for 24 Months
GermanyStudy of Datopotamab Deruxtecan and Pembrolizumab for Patients with Advanced Non-Small Cell Lung Cancer with Low PD-L1 Levels
GermanyStudy Comparing Docetaxel, Darolutamide, and ADT for Patients with Metastatic Hormone-Sensitive Prostate Cancer
GermanyStudy on Ravulizumab for Protecting Chronic Kidney Disease Patients from Acute Kidney Injury After Heart Surgery
GermanyStudy on the Effects of MK-5475 for Adults with Pulmonary Arterial Hypertension
GermanyStudy on Milvexian for Preventing Stroke in Patients with Acute Ischemic Stroke or High-Risk Transient Ischemic Attack
GermanyStudy on JNJ-81201887 for Treating Geographic Atrophy in Age-related Macular Degeneration Patients
GermanyThe busiest research cities in the country
What the registry says about research in the country
Innovative trials focusing on pulmonary hypertension and lung cancer treatments, including evaluation of novel therapies for various stages of NSCLC and rare pulmonary conditions.
Multiple studies are investigating targeted therapies and combination treatments for advanced lung diseases.
Comprehensive research into rare genetic conditions, including Leber congenital amaurosis and Niemann-Pick disease, with trials testing innovative therapeutic approaches.
These studies aim to improve treatment options for patients with rare genetic disorders.
Advanced clinical trials examining new treatments for various cancers, particularly focusing on head and neck cancer and innovative immunotherapy combinations.
Studies are evaluating novel drug combinations and targeted therapies for better treatment outcomes.
Tell us about your condition – we search every trial in Europe and connect you with the right site.
